technetium-tc-99m-medronate and Waldenstrom-Macroglobulinemia
technetium-tc-99m-medronate has been researched along with Waldenstrom-Macroglobulinemia* in 4 studies
Other Studies
4 other study(ies) available for technetium-tc-99m-medronate and Waldenstrom-Macroglobulinemia
Article | Year |
---|---|
Simultaneously significant hepatic and mild splenic uptake of Tc-99m MDP resulting from Waldenstrom macroglobulinemia.
Topics: Female; Humans; Liver; Middle Aged; Paraproteins; Positron-Emission Tomography; Radiopharmaceuticals; Spleen; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Waldenstrom Macroglobulinemia; Whole Body Imaging | 2009 |
Scintigraphic pattern of skeletal involvement of Waldenström macroglobulinemia.
Topics: Adult; Bone Diseases; Humans; Male; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Waldenstrom Macroglobulinemia | 2008 |
Lung uptake on a bone scan: a case of pulmonary Waldenstrom's macroglobulinemia.
Pulmonary involvement secondary to Waldenstrom's macroglobulinemia (WMG) is described in a 40-year-old male by incidental findings on a bone scan. He was examined for right leg pain, and bone scan revealed unexpected pulmonary uptake of Tc-99m MDP. CT scan of the thorax revealed pleural effusion and slightly disseminated micronoduler density increase in the right lung and parenchymal infiltration in the left lung. Transdermal lung biopsy demonstrated diffuse infiltration of lymphoplasmocytoids. Reporting the presence of pulmonary involvement is important because it may prevent morbidity from pulmonary dysfunction. Topics: Adult; Bone and Bones; Humans; Incidental Findings; Leg; Lung; Lung Diseases; Male; Pain; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Waldenstrom Macroglobulinemia; Whole-Body Counting | 2002 |
"Supernormal" bone image in a case of Waldenström macroglobulinemia.
A case of Waldenström macroglobulinemia, a rare cause of diffusely increased skeletal uptake and relatively diminished renal uptake of bone seeking radiopharmaceutical, is presented. This pattern has been described in a variety of disorders. An important observation to be made in these cases is the skeletal distribution of the radiopharmaceutical. In diffuse bone metastases from carcinoma, which is the most common cause of these findings, the increased activity is primarily in the axial skeleton. In some of the more uncommon causes, including certain hematologic disorders, however, the increased skeletal uptake is more homogeneous in distribution, with prominent uptake in the skull and distal extremities. Topics: Aged; Bone and Bones; Female; Humans; Radionuclide Imaging; Technetium Tc 99m Medronate; Waldenstrom Macroglobulinemia | 1986 |